P Squared Asset Management Ag Crispr Therapeutics Ag Transaction History
P Squared Asset Management Ag
- $219 Million
- Q4 2024
A detailed history of P Squared Asset Management Ag transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, P Squared Asset Management Ag holds 3,500 shares of CRSP stock, worth $143,115. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,500Holding current value
$143,115% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CRSP
# of Institutions
488Shares Held
64.1MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$367 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$358 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$156 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$114 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.75MShares$112 Million1.21% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.19B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....